EMA Use of Real-World Data in Safety Signal Evaluation
Utilization of Real-World Data by EMA in Evaluating Safety Signals Key Takeaways Real-world data (RWD) plays a crucial role in enhancing pharmacovigilance efforts by providing insights beyond controlled clinical trials. The European Medicines Agency (EMA) leverages RWD to identify and evaluate safety signals, ensuring drug safety and efficacy in real-world…